RESUMO
OBJECTIVE: This study investigated the ability of endogenous lubricin secretion to restore joint health following a brief <21 day, postnatal lubricin-null state, in a C57BL/6J Prg4 gene trap (GT) mouse under the control of cre-recombinase. Previously we showed that re-expression of lubricin at 21 days was partly restorative of joint lubrication. DESIGN: The tibio-femoral joints of adult C57BL/6J mice containing lubricin, lacking lubricin, and postnatally lacking lubricin until restoration of lubricin expression at 7 days or 14 days of age were evaluated ex vivo. At 8-weeks of age, whole joint coefficient of friction (COF), and caspase-3 activation were measured and the tibial-femoral joints histologically analyzed for degenerative changes, following progressive cyclic loading. The peroxynitrite content of femoral head cartilage from these mice prior to cyclic loading was measured. RESULTS: Mice that underwent gene recombination at 7 and 14 days of age did not reestablish low COF as joint cycling time increased and were histopathologically indistinguishable from the joints of lubricin-null littermates. However, cartilage from tibio-femoral joints that underwent recombination at 7 and 14 days of age had significantly fewer caspase-3 positive cells and significantly reduced peroxynitrite content compared to lubricin-null littermates. CONCLUSIONS: The biological effects of lubricin, which include limiting inflammation via peroxynitrite production and caspase-3 activation, may be achieved without completely restituting low COF. However, fully recapitulating low COF may require undamaged cartilage surfaces or absence of biofouling, which may interfere with the activity of lubricin.
Assuntos
Artrite Experimental/terapia , Caspase 3/metabolismo , Condrócitos/metabolismo , Ácido Peroxinitroso/metabolismo , Proteoglicanas/fisiologia , Animais , Artrite Experimental/metabolismo , Artrite Experimental/patologia , Cartilagem Articular/metabolismo , Cartilagem Articular/patologia , Feminino , Fricção , Terapia Genética/métodos , Masculino , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Proteoglicanas/deficiência , Proteoglicanas/genética , Suporte de CargaRESUMO
Mechanisms of bone formation and skeletal development have been successfully investigated in zebrafish using a variety of in vivo approaches, but in vitro studies have been hindered due to a lack of homologous cell lines capable of producing an extracellular matrix (ECM) suitable for mineral deposition. Here we describe the development and characterization of a new cell line termed ZFB1, derived from zebrafish calcified tissues. ZFB1 cells have an epithelium-like phenotype, grow at 28°C in a regular L-15 medium supplemented with 15% of fetal bovine serum, and are maintained and manipulated using standard methods (e.g., trypsinization, cryopreservation, and transfection). They can therefore be propagated and maintained easily in most cell culture facilities. ZFB1 cells show aneuploidy with 2n=78 chromosomes, indicative of cell transformation. Furthermore, because DNA can be efficiently delivered into their intracellular space by nucleofection, ZFB1 cells are suitable for gene targeting approaches and for assessing gene promoter activity. ZFB1 cells can also differentiate toward osteoblast or chondroblast lineages, as demonstrated by expression of osteoblast- and chondrocyte-specific markers, they exhibit an alkaline phosphatase activity, a marker of bone formation in vivo, and they can mineralize their ECM. Therefore, they represent a valuable zebrafish-derived in vitro system for investigating bone cell differentiation and extracellular matrix mineralization.
Assuntos
Desenvolvimento Ósseo/fisiologia , Diferenciação Celular/fisiologia , Linhagem Celular , Matriz Extracelular/metabolismo , Peixe-Zebra , Animais , Calcificação Fisiológica , Matriz Extracelular/fisiologia , Regulação da Expressão Gênica no Desenvolvimento , Proteoglicanas/metabolismo , Proteoglicanas/fisiologiaRESUMO
Osteoarthritis is a complex disease involving the mechanical breakdown of articular cartilage in the presence of altered joint mechanics and chondrocyte death, but the connection between these factors is not well established. Lubricin, a mucinous glycoprotein encoded by the PRG4 gene, provides boundary lubrication in articular joints. Joint friction is elevated and accompanied by accelerated cartilage damage in humans and mice that have genetic deficiency of lubricin. Here, we investigated the relationship between coefficient of friction and chondrocyte death using ex vivo and in vitro measurements of friction and apoptosis. We observed increases in whole-joint friction and cellular apoptosis in lubricin knockout mice compared with wild-type mice. When we used an in vitro bovine explant cartilage-on-cartilage bearing system, we observed a direct correlation between coefficient of friction and chondrocyte apoptosis in the superficial layers of cartilage. In the bovine explant system, the addition of lubricin as a test lubricant significantly lowered the static coefficient of friction and number of apoptotic chondrocytes. These results demonstrate a direct connection between lubricin, boundary lubrication, and cell survival and suggest that supplementation of synovial fluid with lubricin may be an effective treatment to prevent cartilage deterioration in patients with genetic or acquired deficiency of lubricin.
Assuntos
Apoptose , Condrócitos/patologia , Glicoproteínas/fisiologia , Proteoglicanas/fisiologia , Animais , Cartilagem/metabolismo , Caspase 3/metabolismo , Bovinos , Adesão Celular , Sobrevivência Celular , Genótipo , Marcação In Situ das Extremidades Cortadas , Técnicas In Vitro , Masculino , Camundongos , Camundongos Knockout , Osteoartrite/patologia , Osteoartrite/terapia , Proteoglicanas/genética , Resistência ao Cisalhamento , Estresse MecânicoAssuntos
Córtex Cerebral/citologia , Córtex Cerebral/embriologia , Vias Neurais/embriologia , Potenciais de Ação/fisiologia , Animais , Axônios/fisiologia , Caderinas/fisiologia , Córtex Cerebral/fisiologia , Efrinas/fisiologia , Neurônios/fisiologia , Proteoglicanas/fisiologia , Semaforinas/fisiologia , Fator de Células-Tronco/fisiologia , Transmissão Sináptica/genética , Transmissão Sináptica/fisiologia , Tálamo/embriologia , Tálamo/fisiologiaRESUMO
OBJECTIVE: To determine if recombinant human hemangiopoietin (HAPO), a novel growth factor for primitive cells of hematopoietic and endothelial cell lineages, accelerates hematopoietic reconstitution after high-dose chemotherapy in vivo in mice. METHODS: Male Balb/c mice after treatment of 5-fluorouracil were subcutaneously injected with HAPO or its dilution for consecutive 10 d. Their survival and body weight together with peripheral blood were routinely tested. At day 7 and 14, the numbers of bone marrow (BM) cells as well as colony-forming units (CFU) after in vitro colony culture were counted. The peripheral blood CFU and the percentage of CD34+ CD117+ cells in BM were analyzed. Transwell chamber was used for cell migratory assay. RESULTS: HAPO at different doses significantly increased the survival rate and body weight, with an optimal effect in the HAPO 10 microg/d group. The number of BM cells and the percentage of CD34+ CD117+ cells were also increased after HAPO administration. The number of granulocyte/macrophage CFU and granulocyte, erythroid, macrophage and megakaryocyte CFU in BM after HAPO treatment was greater than that from the HAPO dilution group. More circulating CFU could be observed after injection of HAPO. In addition, this novel cytokine had a chemotactic effect on the hematopoietic stem/progenitor cells. CONCLUSION: HAPO improves animal survival and accelerates hematopoietic reconstitution of mice after high-dose chemotherapy.
Assuntos
Antineoplásicos/farmacologia , Proteoglicanas/fisiologia , Animais , Antígenos CD34/biossíntese , Peso Corporal , Células da Medula Óssea/metabolismo , Movimento Celular , Proliferação de Células , Fluoruracila/farmacologia , Humanos , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Proteínas Proto-Oncogênicas c-kit/biossíntese , Células-TroncoRESUMO
Agouti-related protein (AGRP) plays a key role in energy homeostasis. The carboxyl-terminal domain of AGRP acts as an endogenous antagonist of the melanocortin-4 receptor (MC4-R). It has been suggested that the amino-terminal domain of AGRP binds to syndecan-3, thereby modulating the effects of carboxyl-terminal AGRP at the MC4-R. This model assumes that AGRP is secreted as a full-length peptide. In this study we found that AGRP is processed intracellularly after Arg(79)-Glu(80)-Pro(81)-Arg(82). The processing site suggests cleavage by proprotein convertases (PCs). RNA interference and overexpression experiments showed that PC1/3 is primarily responsible for cleavage in vitro, although both PC2 and PC5/6A can also process AGRP. Dual in situ hybridization demonstrated that PC1/3 is expressed in AGRP neurons in the rat hypothalamus. Moreover, hypothalamic extracts from PC1-null mice contained 3.3-fold more unprocessed full-length AGRP, compared with wild-type mice, based on combined HPLC and RIA analysis, demonstrating that PC1/3 plays a role in AGRP cleavage in vivo. We also found that AGRP(83-132) is more potent an antagonist than full-length AGRP, based on cAMP reporter assays, suggesting that posttranslational cleavage is required to potentiate the effect of AGRP at the MC4-R. Because AGRP is cleaved into distinct amino-terminal and carboxyl-terminal peptides, we tested whether amino-terminal peptides modulate food intake. However, intracerebroventricular injection of rat AGRP(25-47) and AGRP(50-80) had no effect on body weight, food intake, or core body temperature. Because AGRP is cleaved before secretion, syndecan-3 must influence food intake independently of the MC4-R.
Assuntos
Glicoproteínas de Membrana/fisiologia , Fragmentos de Peptídeos/metabolismo , Pró-Proteína Convertase 1/fisiologia , Processamento de Proteína Pós-Traducional , Proteoglicanas/fisiologia , Receptor Tipo 4 de Melanocortina/fisiologia , Proteína Relacionada com Agouti , Animais , Metabolismo Energético/efeitos dos fármacos , Hipotálamo/metabolismo , Peptídeos e Proteínas de Sinalização Intercelular , Masculino , Hormônios Peptídicos/farmacologia , Ratos , Ratos Sprague-Dawley , Sindecana-3RESUMO
Physiological calcification begins from crystallization of hydroxyapatite in extracellular matrix of both bones and teeth. Because calcification is exactly the extracellular event, organic components of extracellular matrix play important roles in control of calcification. The authors discuss the molecular regulation of calcification by organic components of extracellular matrix, focusing on the mineral/organic interaction.
Assuntos
Calcificação Fisiológica/fisiologia , Matriz Extracelular/metabolismo , Ácido 1-Carboxiglutâmico/fisiologia , Animais , Osso e Ossos/metabolismo , Cálcio/metabolismo , Colágeno/metabolismo , Cristalização , Durapatita/metabolismo , Humanos , Osteocalcina/fisiologia , Osteonectina/fisiologia , Osteopontina , Fosfolipídeos/metabolismo , Fósforo/metabolismo , Proteoglicanas/fisiologia , Sialoglicoproteínas/fisiologia , Dente/metabolismoRESUMO
DEGRADATION AND REPAIR: Osteoarthritis generally occurs in a context of an overloaded normal cartilage matrix or normal loading of a vulnerable cartilage matrix. Interleukin-1 appears to be principally indicated in degradation phenomena while transforming growth factor (TGFbeta) is mainly implicated in phenomena of excessive synovial and chondrocyte repair observed at the same time as degradation. MECHANISMS OF ACTION OF DIACEREIN: Diacerein is a slow acting symptomatic treatment of osteoarthritis which has demonstrated efficacy on functional manifestations of osteoarthritis and on the structural component. Two mechanisms of action have been validated: in vitro inhibition of interleukin-1 (IL-1) synthesis, the main cytokine involved in cartilage destruction, and activity on the synthesis of proteoglycans, and hyaluronic acid, the principal component of cartilage. Other studies presented here have provided further details concerning other mechanisms of action of diacerein.
Assuntos
Antraquinonas/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Interleucina-1/antagonistas & inibidores , Osteoartrite/tratamento farmacológico , Animais , Antraquinonas/imunologia , Antraquinonas/farmacologia , Anti-Inflamatórios não Esteroides/imunologia , Anti-Inflamatórios não Esteroides/farmacologia , Condrócitos/efeitos dos fármacos , Condrócitos/imunologia , Modelos Animais de Doenças , Progressão da Doença , Avaliação Pré-Clínica de Medicamentos , Humanos , Ácido Hialurônico/fisiologia , Osteoartrite/imunologia , Osteoartrite/patologia , Proteoglicanas/efeitos dos fármacos , Proteoglicanas/fisiologia , Ensaios Clínicos Controlados Aleatórios como Assunto , Fatores de Crescimento Transformadores/imunologia , Resultado do TratamentoRESUMO
Endocan is a proteoglycan specifically secreted by endothelial cells. Through its glycan domains, endocan binds to hepatocyte growth factor and increases its mitogenic activity. Here, we show that human embryonic kidney 293 cells, which have been genetically engineered to overexpress endocan, form tumors when injected s.c. in SCID mice. Both the glycan and a phenylalanine-rich region of endocan are necessary for mediating tumor growth activity. Blocking the phenylalanine-rich region with a monoclonal antibody results in a marked reduction of tumor growth. Finally, we report that circulating levels of endocan are increased in mice with the endocan-expressing human embryonic kidney 293 cell tumors and in a series of adult patients with lung cancer. Taken together, these results suggest that (a) endothelial-derived endocan induces tumor growth, (b) antibodies to endocan may have therapeutic potential, and (c) circulating levels of endocan may eventually represent a novel marker for cancer.
Assuntos
Transformação Celular Neoplásica/metabolismo , Proteínas de Neoplasias , Proteoglicanas/fisiologia , Animais , Linhagem Celular Tumoral , DNA Complementar/genética , Células HT29 , Humanos , Neoplasias Renais/metabolismo , Neoplasias Renais/patologia , Neoplasias Pulmonares/sangue , Neoplasias Pulmonares/patologia , Masculino , Camundongos , Camundongos SCID , Fenilalanina/metabolismo , Fenilalanina/fisiologia , Proteoglicanas/biossíntese , Proteoglicanas/genética , Proteoglicanas/metabolismo , TransfecçãoRESUMO
Cancer has been attributed to 3 causes: pollution, infection, and poor nutrition. Conventional treatments include surgery, chemotherapy, and radiotherapy. The author proposes that immunotherapy also be considered. Among other environmental influences, dietary deficiencies and carcinogenic viral infections must be investigated and treated wherever possible. It has been suggested that mushrooms, in particular, have a structure that is immunomodulatory because it resembles the proteoglycan structure in the human extracellular matrix, and both are metabolically active. Inasmuch as mitochondria have a bacterial origin, proteoglycans may have a mushroom origin. The author describes a study which shows that natural killer cells can double in number with 8 wk of treatment with Coriolus versicolor. Also described is an epidemiological survey of cancer deaths among Flammulina velutipes farmers in Japan, which found that the mushroom farmers had lower rates of cancer deaths than controls who were not involved in mushroom farming.
Assuntos
Adjuvantes Imunológicos/uso terapêutico , Agaricales , Proteínas da Matriz Extracelular , Neoplasias/terapia , Fitoterapia/métodos , Adjuvantes Imunológicos/farmacologia , Agaricales/química , Agaricales/imunologia , Agrecanas , Membrana Basal/fisiologia , Evolução Biológica , Terapia Combinada , Decorina , Proteínas Fúngicas/uso terapêutico , Humanos , Lectinas Tipo C , Neoplasias/epidemiologia , Neoplasias/etiologia , Fitoterapia/normas , Polissacarídeos/fisiologia , Proteoglicanas/química , Proteoglicanas/fisiologia , Proteoglicanas/uso terapêutico , Ribonucleases/fisiologia , Fatores de Risco , Resultado do TratamentoRESUMO
The cell-surface heparan sulfate proteoglycan syndecan-4 acts in conjunction with the alpha(5)beta(1) integrin to promote the formation of actin stress fibers and focal adhesions in fibronectin (FN)-adherent cells. Fibroblasts seeded onto the cell-binding domain (CBD) fragment of FN attach but do not fully spread or form focal adhesions. Activation of Rho, with lysophosphatidic acid (LPA), or protein kinase C, using the phorbol ester phorbol 12-myristate 13-acetate, or clustering of syndecan-4 with antibodies directed against its extracellular domain will stimulate formation of focal adhesions and stress fibers in CBD-adherent fibroblasts. The distinct morphological differences between the cells adherent to the CBD and to full-length FN suggest that syndecan-4 may influence the organization of the focal adhesion or the activation state of the proteins that comprise it. FN-null fibroblasts (which express syndecan-4) exhibit reduced phosphorylation of focal adhesion kinase (FAK) tyrosine 397 (Tyr(397)) when adherent to CBD compared with FN-adherent cells. Treating the CBD-adherent fibroblasts with LPA, to activate Rho, or the tyrosine phosphatase inhibitor sodium vanadate increased the level of phosphorylation of Tyr(397) to match that of cells plated on FN. Treatment of the fibroblasts with PMA did not elicit such an effect. To confirm that this regulatory pathway includes syndecan-4 specifically, we examined fibroblasts derived from syndecan-4-null mice. The phosphorylation levels of FAK Tyr(397) were lower in FN-adherent syndecan-4-null fibroblasts compared with syndecan-4-wild type and these levels were rescued by the addition of LPA or re-expression of syndecan-4. These data indicate that syndecan-4 ligation regulates the phosphorylation of FAK Tyr(397) and that this mechanism is dependent on Rho but not protein kinase C activation. In addition, the data suggest that this pathway includes the negative regulation of a protein-tyrosine phosphatase. Our results implicate syndecan-4 activation in a direct role in focal adhesion regulation.
Assuntos
Glicoproteínas de Membrana/fisiologia , Proteínas Tirosina Quinases/metabolismo , Proteoglicanas/fisiologia , Animais , Western Blotting , Adesão Celular , Células Cultivadas , DNA Complementar/metabolismo , Fibroblastos/metabolismo , Fibronectinas/metabolismo , Quinase 1 de Adesão Focal , Proteína-Tirosina Quinases de Adesão Focal , Cinética , Glicoproteínas de Membrana/metabolismo , Camundongos , Microscopia de Fluorescência , Modelos Biológicos , Fosforilação , Proteína Quinase C/metabolismo , Estrutura Terciária de Proteína , Proteínas Tirosina Fosfatases/antagonistas & inibidores , Proteoglicanas/metabolismo , Transdução de Sinais , Sindecana-4 , Acetato de Tetradecanoilforbol/farmacologia , Transfecção , Tirosina/metabolismo , Vanadatos/farmacologia , Proteínas rho de Ligação ao GTP/metabolismoRESUMO
Using expression cloning to screen a human fetal kidney cDNA library for regulator(s) of pro-matrix metalloproteinase (MMP)-2 processing mediated by membrane-type (MT) 1 MMP, we isolated a cDNA whose product interfered with pro-MMP-2 activation. It encodes the NH(2)-terminal 313-amino acid region of a calcium-binding proteoglycan, testican 3, with a 3-amino acid substitution at the COOH terminus and thus was named N-Tes. N-Tes comprises a signal peptide, a unique domain, a follistatin-like domain, and a Ca(2+)-binding domain but lacks a COOH-terminal thyroglobulin domain and two putative glycosaminoglycan attachment sites of testican 3. Pro-MMP-2 activation by MT3-MMP was also inhibited by the coexpression of N-Tes. Immunoprecipitation analysis demonstrated direct interaction of N-Tes with either MT1-MMP or MT3-MMP. Expression of testican 1 or testican 3 but not testican 2 also inhibited pro-MMP-2 activation by either MT1-MMP or MT3-MMP. Deletion and substitution of amino acids residues in N-Tes revealed that the unique NH(2)-terminal domain of N-Tes is responsible for the inhibition of pro-MMP-2 activation by MT-MMPs. Expression of N-Tes and testican 3 was detected in normal brain but down-regulated in glioma tissues. Transfection of either the N-Tes or testican 3 gene into U251 glioma cells or Madin-Darby canine kidney cells transformed by erbB2 suppressed their invasive growth in collagen gel. These results suggest that both N-Tes and testican 3 would interfere with tumor invasion by inhibiting MT-MMPs.
Assuntos
Precursores Enzimáticos/antagonistas & inibidores , Gelatinases/antagonistas & inibidores , Metaloendopeptidases/antagonistas & inibidores , Proteoglicanas/fisiologia , Processamento Alternativo , Sequência de Aminoácidos , Animais , Clonagem Molecular , DNA Complementar/genética , Cães , Regulação para Baixo , Ativação Enzimática , Precursores Enzimáticos/metabolismo , Gelatinases/metabolismo , Biblioteca Gênica , Glioma/enzimologia , Glioma/genética , Glioma/patologia , Humanos , Rim/citologia , Rim/fisiologia , Metaloproteinase 16 da Matriz , Metaloproteinases da Matriz Associadas à Membrana , Metaloendopeptidases/metabolismo , Dados de Sequência Molecular , Mapeamento de Peptídeos , Isoformas de Proteínas , Sinais Direcionadores de Proteínas/genética , Estrutura Terciária de Proteína , Proteoglicanas/biossíntese , Proteoglicanas/genética , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Transfecção , Células Tumorais CultivadasRESUMO
Transgenic expression in the hypothalamus of syndecan-1, a cell surface heparan sulfate proteoglycan (HSPG) and modulator of ligand-receptor encounters, produces mice with hyperphagia and maturity-onset obesity resembling mice with reduced action of alpha melanocyte stimulating hormone (alphaMSH). Via their HS chains, syndecans potentiate the action of agouti-related protein and agouti signaling protein, endogenous inhibitors of alphaMSH. In wild-type mice, syndecan-3, the predominantly neural syndecan, is expressed in hypothalamic regions that control energy balance. Food deprivation increases hypothalamic syndecan-3 levels several-fold. Syndecan-3 null mice, otherwise apparently normal, respond to food deprivation with markedly reduced reflex hyperphagia. We propose that oscillation of hypothalamic syndecan-3 levels physiologically modulates feeding behavior.
Assuntos
Comportamento Alimentar/fisiologia , Hipotálamo/fisiologia , Glicoproteínas de Membrana/fisiologia , Proteoglicanas/fisiologia , Envelhecimento/fisiologia , Sequência de Aminoácidos , Animais , Glicemia/metabolismo , Corticosterona/sangue , Feminino , Fator 2 de Crescimento de Fibroblastos/metabolismo , Privação de Alimentos , Humanos , Hiperfagia/genética , Hiperfagia/fisiopatologia , Insulina/sangue , Leptina/sangue , Masculino , Glicoproteínas de Membrana/química , Glicoproteínas de Membrana/deficiência , Glicoproteínas de Membrana/genética , Camundongos , Camundongos Knockout , Camundongos Transgênicos , Dados de Sequência Molecular , Mutagênese , Obesidade/genética , Obesidade/fisiopatologia , Proteoglicanas/química , Proteoglicanas/deficiência , Proteoglicanas/genética , Receptores de Fatores de Crescimento de Fibroblastos/fisiologia , Sindecana-1 , Sindecana-3 , Sindecanas , alfa-MSH/metabolismoRESUMO
BACKGROUND: The small chondroitin/dermatan sulphate proteoglycans decorin and biglycan participate in organizing the network of collagen fibrils and interact with non-collagenous matrix proteins. In addition, via interactions with cytokines they are directly or indirectly involved in signalling, growth and cell differentiation. We aimed to analyse their expression in normal gastric tissue and during gastric ulcer healing. METHODS: Proteoglycan expression was studied by immunohistochemistry and in situ hybridization in acetic acid-induced gastric ulcers in rat during early phases and during chronic ulceration. The effects of treatment with an acid stable mutein of FGF-2 (bFGF) were also studied. RESULTS: In normal gastric tissue, both proteoglycans were most strongly expressed in the submucosal layer. However, some epithelial cells were positive for biglycan and, surprisingly, also for decorin. In the early phase after ulcer induction exclusively decorin became induced in the muscularis mucosae, while biglycan became detectable in this layer only after 2 weeks. There was no up-regulation of either proteoglycan in other layers, nor could an effect of FGF-2 treatment be seen. CONCLUSIONS: The expression of decorin could be observed for the first time in epithelial cells. Decorin, but not biglycan, appears as an early phase reactant in the muscularis mucosae in accordance with its putative role during angiogenesis and the prevention of apoptosis.
Assuntos
Modelos Animais de Doenças , Fator 2 de Crescimento de Fibroblastos/farmacologia , Mucosa Gástrica/anatomia & histologia , Mucosa Gástrica/efeitos dos fármacos , Expressão Gênica/efeitos dos fármacos , Expressão Gênica/fisiologia , Proteoglicanas/efeitos dos fármacos , Proteoglicanas/fisiologia , Úlcera Gástrica/tratamento farmacológico , Úlcera Gástrica/patologia , Cicatrização/efeitos dos fármacos , Cicatrização/fisiologia , Ácido Acético , Animais , Apoptose/efeitos dos fármacos , Apoptose/fisiologia , Biglicano , Decorina , Avaliação Pré-Clínica de Medicamentos , Proteínas da Matriz Extracelular , Mucosa Gástrica/fisiologia , Imuno-Histoquímica , Masculino , Neovascularização Fisiológica/efeitos dos fármacos , Neovascularização Fisiológica/fisiologia , Ratos , Ratos Wistar , Úlcera Gástrica/induzido quimicamente , Fatores de Tempo , Regulação para CimaRESUMO
Testican is a putative extracellular heparan/ chondroitin sulfate proteoglycan of unknown function that is expressed in a variety of human tissues at widely different levels but is most abundant in the brain. In mice, testican mRNA has been detected only in brain and it is therefore likely to have an important function in the central nervous system. RNA blot analysis reveals the relative intensity of testican in various regions of the human brain. Levels of testican message are most pronounced in the thalamus, hippocampus, occipital lobe, nucleus accumbens, temporal lobe, and caudate nucleus, with somewhat lower levels in the cerebral cortex, medulla oblongata, frontal lobe, amygdala, putamen, spinal cord, substantia nigra, and cerebellum. In situ hybridization reveals the cellular distribution of the mRNA within these areas to be highest in neurons and in choroid plexus epithelium, and moderately lower in ependymal cells lining the ventricles and in vascular endothelial cells. Testican mRNA is not detected in oligodendrocytes or in most astrocytes. However, astrocytes in regions of reactive gliosis do express testican mRNA. These findings, along with a cysteine-rich pattern similarity to neurocan, brevican, versican, and other proteoglycans found in brain, suggest that testican may be a part of the specialized extracellular matrix of the brain.
Assuntos
Encéfalo/metabolismo , Proteoglicanas/metabolismo , Gânglios da Base/metabolismo , Encéfalo/anatomia & histologia , Tronco Encefálico/metabolismo , Cerebelo/metabolismo , Córtex Cerebral/metabolismo , Plexo Corióideo/metabolismo , Proteínas da Matriz Extracelular/genética , Proteínas da Matriz Extracelular/metabolismo , Proteínas da Matriz Extracelular/fisiologia , Hipocampo/metabolismo , Humanos , Hipotálamo/metabolismo , Hibridização In Situ , Hipófise/metabolismo , Proteoglicanas/genética , Proteoglicanas/fisiologia , RNA Mensageiro/biossíntese , Transcrição GênicaRESUMO
The leucine-rich proteoglycan decorin interacts with the epidermal growth factor receptor and triggers a signaling pathway that leads to growth suppression. We find that decorin causes a functional inactivation of the oncogenic ErbB2 protein in breast carcinoma cells. Upon de novo expression of decorin, the ErbB2 protein is reduced by approximately 40%, whereas its degree of tyrosyl phosphorylation is almost completely abrogated. Both co-culture experiments or experiments with recombinant decorin demonstrate an initial induction of ErbB2 tyrosine kinase, followed by a profound and long-lasting down-regulation of its activity. This leads to growth inhibition and cytodifferentiation of mammary tumor cells and a concurrent suppression of their tumorigenic potential in vivo. These decorin-mediated effects appear to involve the activation of ErbB4, which in turn would block the phosphorylation of heterodimers containing either ErbB2 or ErbB3. These results provide an explanation for the heightened decorin levels around invasive carcinomas and suggest that decorin may function as a natural antagonist of neoplastic cells enriched in ErbB2.
Assuntos
Regulação para Baixo , Proteoglicanas/fisiologia , Receptor ErbB-2/metabolismo , Animais , Northern Blotting , Western Blotting , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/metabolismo , Adesão Celular , Ciclo Celular , Diferenciação Celular , Divisão Celular , Separação Celular , Técnicas de Cocultura , DNA Complementar/metabolismo , Decorina , Relação Dose-Resposta a Droga , Ativação Enzimática , Receptores ErbB/metabolismo , Proteínas da Matriz Extracelular , Citometria de Fluxo , Humanos , Imuno-Histoquímica , Cinética , Leucina/química , Camundongos , Fenótipo , Fosforilação , Testes de Precipitina , Proteoglicanas/farmacologia , Receptor ErbB-3/metabolismo , Receptor ErbB-4 , Proteínas Recombinantes/metabolismo , Transdução de Sinais , Fatores de Tempo , Transfecção , Células Tumorais Cultivadas , Tirosina/metabolismoRESUMO
OBJECTIVE: To examine the interactions of low density lipoprotein-B (LDL-B) with proteoglycans (PG) in vitro. DESIGN: The PG were isolated from human aortas, removed at autopsy by a combination of extraction with 4M guanidine-Tris buffer containing protease inhibitors and fractionation on a DEAE-Sephacel ion-exchange chromatography column. LDL and LDL-B from healthy or hyperapobetalipoproteinemic sera, respectively, were isolated by standard density flotation techniques followed by radioiodination. Radiolabelled lipoproteins (LP) were incubated with proteoglycans at 4 or 37 degrees C in a low ionic strength buffer with or without addition of polyethylene glycol (PEG) which was used to enhance precipitation of the resulting LP-PG complexes. MAIN RESULTS: Data revealed that a specific ratio of LP to PG is a prerequisite for optimal interactions between these macromolecules. Further, it was observed that LDL-B forms fewer precipitable complexes than normal LDL at 4 degrees C. However, at physiological temperature or with the addition of PEG, precipitation of the two LDLs was equal. CONCLUSION: LDL and LDL-B showed equal reactivity with PG in terms of precipitable complexes.
Assuntos
Aorta/química , Hiperlipoproteinemia Tipo II/sangue , Lipoproteínas LDL/farmacologia , Proteoglicanas/farmacologia , Precipitação Química , Avaliação Pré-Clínica de Medicamentos , Interações Medicamentosas , Humanos , Lipoproteínas LDL/sangue , Lipoproteínas LDL/fisiologia , Proteoglicanas/química , Proteoglicanas/fisiologia , SolubilidadeRESUMO
Joint cartilage consists of cells embedded in a matrix of fibrous collagen within a concentrated water-proteoglycan gel. The integrity of this matrix is crucial for the biomechanical properties of the joint cartilage. The different components of the matrix are synthesized and degraded by the cartilage cells, a process regulated by the amount of mechanical stress applied to the chondrocytes as well as by peptide factors and hormones present in synovial fluid. The proteoglycans are large macromolecules consisting of a protein core to which are attached multiple chains of glycosaminoglycans and oligosaccharides. During normal and pathological turnover, degradation products are released to the synovial fluid and to the circulation. Newly developed assays allow the sensitive and specific detection of these fragments in joint fluid and serum. Results of experimental and clinical investigations suggest that these assays will be of value in efforts to diagnose, grade and predict the outcome of inflammatory and degenerative joint disease.